Lactose India shares jumped 7.15% to ₹128.95 following the company's impressive fourth quarter results. According to reports from Business Standard, the pharmaceutical company's stock movement reflects investor confidence in the strong financial performance demonstrated during the quarter.
The company reported a remarkable 193.74% surge in consolidated net profit to ₹1.88 crore in Q4 FY26, compared with ₹0.64 crore in the corresponding quarter of the previous year. As reported by Business Standard, this substantial profit growth indicates significant operational efficiency improvements during the quarter.
Revenue from operations soared 64.81% year-on-year to ₹45.77 crore in the quarter ended March 31, 2026. According to the company's financial results, total expenses increased 58.28% year-on-year to ₹43.67 crore during the quarter, compared with ₹27.59 crore in the year-ago period. The cost of materials consumed stood at ₹28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to ₹3.53 crore.
For the full financial year FY26, Lactose India posted a 17.44% rise in consolidated net profit to ₹6.06 crore, while revenue rose 40.28% to ₹163.29 crore compared with FY25. As reported by Business Standard, the company's annual performance demonstrates sustained growth momentum across multiple financial metrics.
Profit before tax (PBT) stood at ₹2.31 crore in Q4 FY26, registering a growth of 320% from ₹0.55 crore reported in Q4 FY25. According to the company's financial statements, this substantial PBT growth indicates strong operational performance and effective cost management during the quarter.
